PHXM — Phaxiam Therapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Phaxiam Therapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	134	73.2	44.5	33.7	38.8
Net Total Accounts Receivable
Net Total Receivables	9.68	5.82	4.33	5.09	3.04
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	150	81.6	49.6	40	42.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.3	35.6	29.1	25.8	2.98
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	168	119	80.4	66.8	45.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.6	19.9	29.3	20	11.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	22.2	33	53.9	43.9	22.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	146	85.6	26.5	22.8	23.5
Total Liabilities & Shareholders' Equity	168	119	80.4	66.8	45.8
Total Common Shares Outstanding